One-Shot gene injection aims to restore sight in genetic blindness trial
NCT ID NCT07406854
Summary
This study is testing whether a single injection of an experimental gene therapy (NR082) into the eye is safe and can improve vision in people with Leber's hereditary optic neuropathy (LHON), a genetic condition that causes vision loss. The trial will enroll about 95 people aged 12 to 75 who have had vision loss for 6 months to 10 years due to a specific genetic mutation. Participants will be randomly assigned to receive either the real gene therapy injection or a sham (pretend) injection in both eyes to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEBER HEREDITARY OPTIC NEUROPATHY (LHON) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.